Logo image of ORA

ORMAT TECHNOLOGIES INC (ORA) Stock Fundamental Analysis

USA - NYSE:ORA - US6866881021 - Common Stock

94 USD
+1.46 (+1.58%)
Last: 9/18/2025, 8:13:20 PM
94 USD
0 (0%)
After Hours: 9/18/2025, 8:13:20 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ORA. ORA was compared to 20 industry peers in the Independent Power and Renewable Electricity Producers industry. While ORA is still in line with the averages on profitability rating, there are concerns on its financial health. ORA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

ORA had positive earnings in the past year.
In the past year ORA had a positive cash flow from operations.
ORA had positive earnings in each of the past 5 years.
ORA had a positive operating cash flow in each of the past 5 years.
ORA Yearly Net Income VS EBIT VS OCF VS FCFORA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

With a decent Return On Assets value of 2.18%, ORA is doing good in the industry, outperforming 80.00% of the companies in the same industry.
ORA's Return On Equity of 5.27% is fine compared to the rest of the industry. ORA outperforms 65.00% of its industry peers.
The Return On Invested Capital of ORA (2.53%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for ORA is in line with the industry average of 4.21%.
Industry RankSector Rank
ROA 2.18%
ROE 5.27%
ROIC 2.53%
ROA(3y)2%
ROA(5y)1.92%
ROE(3y)4.67%
ROE(5y)4.42%
ROIC(3y)2.95%
ROIC(5y)3.25%
ORA Yearly ROA, ROE, ROICORA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ORA has a better Profit Margin (14.49%) than 90.00% of its industry peers.
ORA's Profit Margin has improved in the last couple of years.
ORA's Operating Margin of 19.00% is fine compared to the rest of the industry. ORA outperforms 70.00% of its industry peers.
ORA's Operating Margin has declined in the last couple of years.
ORA has a worse Gross Margin (28.94%) than 65.00% of its industry peers.
In the last couple of years the Gross Margin of ORA has declined.
Industry RankSector Rank
OM 19%
PM (TTM) 14.49%
GM 28.94%
OM growth 3Y-8.17%
OM growth 5Y-5.33%
PM growth 3Y14.53%
PM growth 5Y3.56%
GM growth 3Y-8.05%
GM growth 5Y-3%
ORA Yearly Profit, Operating, Gross MarginsORA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ORA is destroying value.
Compared to 1 year ago, ORA has more shares outstanding
The number of shares outstanding for ORA has been increased compared to 5 years ago.
Compared to 1 year ago, ORA has a worse debt to assets ratio.
ORA Yearly Shares OutstandingORA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ORA Yearly Total Debt VS Total AssetsORA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

ORA has an Altman-Z score of 1.36. This is a bad value and indicates that ORA is not financially healthy and even has some risk of bankruptcy.
ORA has a better Altman-Z score (1.36) than 75.00% of its industry peers.
ORA has a Debt/Equity ratio of 0.85. This is a neutral value indicating ORA is somewhat dependend on debt financing.
ORA has a better Debt to Equity ratio (0.85) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Altman-Z 1.36
ROIC/WACC0.34
WACC7.46%
ORA Yearly LT Debt VS Equity VS FCFORA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

ORA has a Current Ratio of 0.70. This is a bad value and indicates that ORA is not financially healthy enough and could expect problems in meeting its short term obligations.
ORA has a worse Current ratio (0.70) than 70.00% of its industry peers.
ORA has a Quick Ratio of 0.70. This is a bad value and indicates that ORA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.62, ORA is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.62
ORA Yearly Current Assets VS Current LiabilitesORA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

5

3. Growth

3.1 Past

ORA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.90%.
Measured over the past 5 years, ORA shows a small growth in Earnings Per Share. The EPS has been growing by 7.89% on average per year.
ORA shows a small growth in Revenue. In the last year, the Revenue has grown by 2.23%.
Measured over the past years, ORA shows a small growth in Revenue. The Revenue has been growing by 3.35% on average per year.
EPS 1Y (TTM)0.9%
EPS 3Y15.39%
EPS 5Y7.89%
EPS Q2Q%20%
Revenue 1Y (TTM)2.23%
Revenue growth 3Y9.88%
Revenue growth 5Y3.35%
Sales Q2Q%9.89%

3.2 Future

The Earnings Per Share is expected to grow by 19.00% on average over the next years. This is quite good.
The Revenue is expected to grow by 9.16% on average over the next years. This is quite good.
EPS Next Y3.3%
EPS Next 2Y7.18%
EPS Next 3Y10.11%
EPS Next 5Y19%
Revenue Next Year8.62%
Revenue Next 2Y11.6%
Revenue Next 3Y9.86%
Revenue Next 5Y9.16%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ORA Yearly Revenue VS EstimatesORA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B
ORA Yearly EPS VS EstimatesORA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 41.96 indicates a quite expensive valuation of ORA.
Compared to the rest of the industry, the Price/Earnings ratio of ORA indicates a somewhat cheap valuation: ORA is cheaper than 75.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.41. ORA is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 38.60, the valuation of ORA can be described as expensive.
65.00% of the companies in the same industry are more expensive than ORA, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.88. ORA is valued rather expensively when compared to this.
Industry RankSector Rank
PE 41.96
Fwd PE 38.6
ORA Price Earnings VS Forward Price EarningsORA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ORA.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.63
ORA Per share dataORA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ORA does not grow enough to justify the current Price/Earnings ratio.
ORA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)12.73
PEG (5Y)5.32
EPS Next 2Y7.18%
EPS Next 3Y10.11%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.52%, ORA is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.70, ORA pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.52, ORA pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 0.52%

5.2 History

The dividend of ORA has a limited annual growth rate of 1.80%.
ORA has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of ORA decreased recently.
Dividend Growth(5Y)1.8%
Div Incr Years0
Div Non Decr Years1
ORA Yearly Dividends per shareORA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

ORA pays out 22.14% of its income as dividend. This is a sustainable payout ratio.
ORA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP22.14%
EPS Next 2Y7.18%
EPS Next 3Y10.11%
ORA Yearly Income VS Free CF VS DividendORA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M
ORA Dividend Payout.ORA Dividend Payout, showing the Payout Ratio.ORA Dividend Payout.PayoutRetained Earnings

ORMAT TECHNOLOGIES INC

NYSE:ORA (9/18/2025, 8:13:20 PM)

After market: 94 0 (0%)

94

+1.46 (+1.58%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners93.34%
Inst Owner Change1.19%
Ins Owners0.34%
Ins Owner Change0.09%
Market Cap5.71B
Analysts78.57
Price Target97.24 (3.45%)
Short Float %5.14%
Short Ratio6.08
Dividend
Industry RankSector Rank
Dividend Yield 0.52%
Yearly Dividend0.48
Dividend Growth(5Y)1.8%
DP22.14%
Div Incr Years0
Div Non Decr Years1
Ex-Date08-20 2025-08-20 (0.12)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.31%
Min EPS beat(2)17.43%
Max EPS beat(2)25.2%
EPS beat(4)4
Avg EPS beat(4)24.68%
Min EPS beat(4)14.56%
Max EPS beat(4)41.54%
EPS beat(8)7
Avg EPS beat(8)22.11%
EPS beat(12)11
Avg EPS beat(12)22.91%
EPS beat(16)15
Avg EPS beat(16)23.15%
Revenue beat(2)1
Avg Revenue beat(2)1.89%
Min Revenue beat(2)-0.02%
Max Revenue beat(2)3.8%
Revenue beat(4)1
Avg Revenue beat(4)-0.58%
Min Revenue beat(4)-3.28%
Max Revenue beat(4)3.8%
Revenue beat(8)2
Avg Revenue beat(8)-0.49%
Revenue beat(12)4
Avg Revenue beat(12)-1.26%
Revenue beat(16)7
Avg Revenue beat(16)-0.47%
PT rev (1m)3%
PT rev (3m)13.49%
EPS NQ rev (1m)-1.84%
EPS NQ rev (3m)-4.99%
EPS NY rev (1m)3.56%
EPS NY rev (3m)1.15%
Revenue NQ rev (1m)0.24%
Revenue NQ rev (3m)0.55%
Revenue NY rev (1m)0.87%
Revenue NY rev (3m)0.73%
Valuation
Industry RankSector Rank
PE 41.96
Fwd PE 38.6
P/S 6.3
P/FCF N/A
P/OCF 12.69
P/B 2.29
P/tB 2.81
EV/EBITDA 17.63
EPS(TTM)2.24
EY2.38%
EPS(NY)2.44
Fwd EY2.59%
FCF(TTM)-1.89
FCFYN/A
OCF(TTM)7.41
OCFY7.88%
SpS14.93
BVpS41.06
TBVpS33.49
PEG (NY)12.73
PEG (5Y)5.32
Profitability
Industry RankSector Rank
ROA 2.18%
ROE 5.27%
ROCE 3.26%
ROIC 2.53%
ROICexc 2.57%
ROICexgc 2.81%
OM 19%
PM (TTM) 14.49%
GM 28.94%
FCFM N/A
ROA(3y)2%
ROA(5y)1.92%
ROE(3y)4.67%
ROE(5y)4.42%
ROIC(3y)2.95%
ROIC(5y)3.25%
ROICexc(3y)3.03%
ROICexc(5y)3.47%
ROICexgc(3y)3.34%
ROICexgc(5y)3.83%
ROCE(3y)3.78%
ROCE(5y)4.15%
ROICexcg growth 3Y-11.23%
ROICexcg growth 5Y-12.21%
ROICexc growth 3Y-10.01%
ROICexc growth 5Y-12.56%
OM growth 3Y-8.17%
OM growth 5Y-5.33%
PM growth 3Y14.53%
PM growth 5Y3.56%
GM growth 3Y-8.05%
GM growth 5Y-3%
F-Score4
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Debt/EBITDA 4.71
Cap/Depr 204.28%
Cap/Sales 62.33%
Interest Coverage 250
Cash Conversion 100.27%
Profit Quality N/A
Current Ratio 0.7
Quick Ratio 0.62
Altman-Z 1.36
F-Score4
WACC7.46%
ROIC/WACC0.34
Cap/Depr(3y)248.02%
Cap/Depr(5y)235.6%
Cap/Sales(3y)68.92%
Cap/Sales(5y)63.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.9%
EPS 3Y15.39%
EPS 5Y7.89%
EPS Q2Q%20%
EPS Next Y3.3%
EPS Next 2Y7.18%
EPS Next 3Y10.11%
EPS Next 5Y19%
Revenue 1Y (TTM)2.23%
Revenue growth 3Y9.88%
Revenue growth 5Y3.35%
Sales Q2Q%9.89%
Revenue Next Year8.62%
Revenue Next 2Y11.6%
Revenue Next 3Y9.86%
Revenue Next 5Y9.16%
EBIT growth 1Y-3.18%
EBIT growth 3Y0.91%
EBIT growth 5Y-2.16%
EBIT Next Year187.3%
EBIT Next 3Y52.71%
EBIT Next 5Y35.98%
FCF growth 1Y57.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.9%
OCF growth 3Y16.66%
OCF growth 5Y11.68%